R&D Systems™ Recombinant Human IL-17F (NS0-expressed) Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human IL-17F (NS0-expressed) Protein is derived from NS0. The Recombinant Human IL-17F (NS0-expressed) Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: Q96PD4
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 um filtered solution in Acetonitrile and TFA.
• Gene ID (Entrez): 112744
• Molecular Weight (g/mol): 15.7 kDa (monomer)
• Name: IL-17F
• Quantity: 100 μg
• Source: Mouse myeloma cell line,NS0-derived human IL-17F protein Arg31-Gln163,with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Structural Form: Disulfide-linked homodimer
• Gene Symbol: IL17F
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 100 ug/mL in sterile 4 mM HCl.
• Buffer: Lyophilized from a 0.2 um filtered solution in Acetonitrile and TFA.
• Endotoxin Level: <0.10 EU / 1 ug of the protein by the LAL method.
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

For Research Use Only